Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dimeric L-dopa derivatives as potential prodrugs.

A Di Stefano1, B Mosciatti, G M Cingolani

  • 1Dipartimento di Scienze del Farmaco, Università G. D'Annunzio, Chieti, Italy. adistefano@unich.it

Bioorganic & Medicinal Chemistry Letters
|May 1, 2001
PubMed
Summary

New L-Dopa prodrugs, dimeric derivatives of L-Dopa diacetyl esters, demonstrate chemical stability and a slow release of L-Dopa in human plasma, suggesting potential for improved drug delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Litho- and biostratigraphic data of lower-middle Miocene sections in the Transylvanian basin and SE Carpathian Foredeep (Romania).

Data in brief·2019
Same author

Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model.

Biochimie·2019
Same author

Nerve ablation after bronchial thermoplasty and sustained improvement in severe asthma.

BMC pulmonary medicine·2018
Same author

Gold nanoparticles as scaffolds for poor water soluble and difficult to vehiculate antiparkinson codrugs.

Nanotechnology·2016
Same author

Clinical application of shock wave therapy in musculoskeletal disorders: part II related to myofascial and nerve apparatus.

Journal of biological regulators and homeostatic agents·2016
Same author

Toxicity assessment of hydroxyapatite nanoparticles in rat liver cell model in vitro.

Human & experimental toxicology·2015

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Delivery Systems

Background:

  • Levodopa (L-Dopa) is a primary treatment for Parkinson's disease, but its efficacy is limited by poor physicochemical properties.
  • Developing effective L-Dopa prodrugs is crucial for enhancing therapeutic outcomes and patient compliance.

Purpose of the Study:

  • To synthesize and evaluate novel dimeric derivatives of L-Dopa diacetyl esters as potential L-Dopa prodrugs.
  • To assess the physicochemical properties, chemical stability, and drug release characteristics of these new compounds.

Main Methods:

  • Synthesis of dimeric L-Dopa diacetyl ester derivatives (+)-1, (+)-2, and (+)-3a-d.
  • Evaluation of chemical stability in aqueous buffer solutions at pH 1.3 and 7.4.
  • Assessment of L-Dopa release kinetics in human plasma.

Related Experiment Videos

Main Results:

  • All synthesized dimeric L-Dopa derivatives exhibited good chemical stability across a range of pH conditions.
  • The prodrugs demonstrated a controlled and relatively slow release of active L-Dopa in human plasma.
  • The dimeric structure appears to confer favorable physicochemical properties for potential prodrug applications.

Conclusions:

  • The novel dimeric L-Dopa diacetyl ester derivatives represent promising candidates for L-Dopa prodrugs.
  • These compounds offer potential for improved drug delivery and therapeutic efficacy in Parkinson's disease treatment.
  • Further in vivo studies are warranted to fully elucidate their pharmacological potential.